AI Analysis
AI-generated analysis. Always verify with the original filing.
XWELL faced persistent operating losses and cash burn in FY2025, driven by XpresTest revenue declines from reduced testing volumes, partially offset by Naples Wax growth, with closures stabilizing costs amid a post-year-end financing lifeline for liquidity.
Key Takeaways
1Revenue was $29.2M, reflecting declines primarily from reduced XpresTest testing volumes partially offset by new Naples Wax locations.
2Gross profit was $7.5M at 25.7% margin as cost of sales decreased due to Treat business closure and 3 underperforming XpresSpa shutdowns.
3Operating income was -$15.7M (-53.6% margin), reflecting ongoing challenges despite significant reductions in operating and overhead expenses.
4Net income was -$17.0M with diluted EPS of -$5.08, underscoring the impact of segment declines and restructuring costs.
5Free cash flow was -$11.7M from -$8.7M operating cash use and $3.0M capital expenditures.